Histopathological Scoring of Activated Stromal Reaction and its Associations with Tumor Molecular Subtypes and Prognosis in High-Grade Serous Ovarian Carcinoma

被引：0
|
作者：
Yuan, Lin [1 ]
Guo, Ruifeng [2 ]
Wang, Chen [3 ]
Huang, Yajue [2 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai, Peoples R China
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Coll Med, Rochester, MN USA
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1225
引用
收藏
页码：1165 / 1165
页数：1
相关论文
共 50 条
  • [21] Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
    Kim, Se Ik
    Jung, Minsun
    Dan, Kisoon
    Lee, Sungyoung
    Lee, Cheol
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Park, Noh Hyun
    Song, Yong-Sang
    Han, Dohyun
    Lee, Maria
    CANCERS, 2020, 12 (04)
  • [22] Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma
    Arend, Rebecca C.
    Londono, Angelina I.
    Montgomery, Allison M.
    Smith, Haller J.
    Dobbin, Zachary C.
    Katre, Ashwini A.
    Martinez, Alba
    Yang, Eddy S.
    Alvarez, Ronald D.
    Huh, Warner K.
    Bevis, Kerri S.
    Straughn, J. Michael, Jr.
    Estes, Jacob M.
    Novak, Lea
    Crossman, David K.
    Cooper, Sara J.
    Landen, Charles N.
    Leath, Charles A., III
    MOLECULAR CANCER RESEARCH, 2018, 16 (05) : 813 - 824
  • [23] Molecular response to neoadjuvant chemotherapy in high-grade serous ovarian carcinoma
    Montgomery, A. M.
    Crossman, D. K.
    Yang, E. S.
    Alvarez, R. D.
    Huh, W. K.
    Bevis, K. S.
    Straughn, J. M., Jr.
    Leath, C. A., III
    Arend, R. C.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 12 - 13
  • [24] Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging
    Kassuhn, Wanja
    Klein, Oliver
    Darb-Esfahani, Silvia
    Lammert, Hedwig
    Handzik, Sylwia
    Taube, Eliane T.
    Schmitt, Wolfgang D.
    Keunecke, Carlotta
    Horst, David
    Dreher, Felix
    George, Joshy
    Bowtell, David D.
    Dorigo, Oliver
    Hummel, Michael
    Sehouli, Jalid
    Bluthgen, Nils
    Kulbe, Hagen
    Braicu, Elena I.
    CANCERS, 2021, 13 (07)
  • [25] Classification of molecular subtypes of high-grade serous ovarian cancer by MALDI-Imaging.
    Kassuhn, Wanja Nikolai
    Klein, Oliver
    Darb-Esfahani, Silvia
    Lammert, Hedwig
    Handzik, Sylwia
    Taube, Eliane T.
    Schmitt, Wolfgang D.
    Dorigo, Oliver
    Horst, David
    Keunecke, Carlotta
    Dreher, Felix
    George, Joshy
    Bowtell, David
    Hummel, Michael
    Sehouli, Jalid
    Bluethgen, Nils
    Kulbe, Hagen
    Braicu, Elena Ioana
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [26] Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor
    Imamura, Hiroko
    Ohishi, Yoshihiro
    Aman, Murasaki
    Shida, Kaai
    Shinozaki, Tomoko
    Yasutake, Nobuko
    Sonoda, Keno
    Kato, Kiyoko
    Oda, Yoshinao
    HUMAN PATHOLOGY, 2015, 46 (10) : 1455 - 1463
  • [27] OVARIAN HIGH-GRADE SEROUS CARCINOMA WITH NEUROENDOCRINE COMPONENT, A RARE AND AGGRESSIVE TUMOR
    Kumar, V.
    Shalaby, A.
    Manucha, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 (02) : 513 - 514
  • [28] MOLECULAR SUBTYPES OF OVARIAN CANCER: INSIGHTS INTO THE DRIVERS OF HIGH-GRADE OVARIAN SEROUS AND CLEAR CELL TUMOURS
    Bowtell, D. D. L.
    ANNALS OF ONCOLOGY, 2010, 21 : 30 - 30
  • [29] PROTEOMIC DISCOVERY OF BLOOD BIOMARKERS PREDICTING PROGNOSIS OF HIGH-GRADE SEROUS OVARIAN CARCINOMA
    Lee, Seung Jun
    Kim, Se Ik
    Kim, Hee Seung
    Chung, Hyun Hoon
    Kim, Jae-Weon
    Lee, Maria
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A153 - A153
  • [30] Differential expression of estrogen receptor subtypes in ovarian high-grade serous carcinoma and clear cell carcinoma
    Osaku, Daiken
    Oishi, Tetsuro
    Kawamura, Naoshi
    Iida, Yuki
    Komatsu, Hiroaki
    Kudoh, Akiko
    Chikumi, Jun
    Sato, Shinya
    Harada, Tasuku
    REPRODUCTIVE MEDICINE AND BIOLOGY, 2021, 20 (04) : 467 - 476
12345